Home › Funds › Point72 Asset Management › ENTX
Point72 Asset Management position in ENTX
ENTERA BIO LTD · Health Care
Latest position (Q1 2026)12.38K sh
Reported value held$13.74K
Portfolio Weight0.00%
First reportedQ1 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 2.70M | $4.59M | New |
| Q1 2025 | 2.70M | $4.59M | New |
| Q2 2025 | 2.70M | $5.12M | Hold |
| Q2 2025 | 2.70M | $5.12M | Hold |
| Q3 2025 | 1.18M | $2.26M | Reduce |
| Q4 2025 | 1.19M | $2.32M | Add |
| Q1 2026 | 12.38K | $13.74K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ENTX
- Renaissance Technologies 368.85K sh · $652.86K · Q2 2026
- PNC Financial Services 273.03K sh · $483.26K · Q2 2026
- JPMorgan Chase & Co 40.88K sh · $67.46K · Q2 2026
- Geode Capital Management 29.91K sh · $52.94K · Q2 2026
- UBS Group AG 12.72K sh · $22.52K · Q2 2026
- Citadel Advisors 10.10K sh · $17.88K · Q2 2026
- Morgan Stanley 500 sh · $885 · Q2 2026